These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35001031)

  • 1. Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes.
    Nasri A; Sghaier I; Gharbi A; Mrabet S; Ben Djebara M; Gargouri A; Kacem I; Gouider R
    Alzheimer Dis Assoc Disord; 2022 Jan-Mar 01; 36(1):36-43. PubMed ID: 35001031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of APOE in atypical parkinsonism syndromes.
    Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
    Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical parkinsonian syndromes in a North African tertiary referral center.
    Nasri A; Ben Djebara M; Sghaier I; Mrabet S; Zidi S; Gargouri A; Kacem I; Gouider R
    Brain Behav; 2021 Jan; 11(1):e01924. PubMed ID: 33179436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
    Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
    Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.
    Morris HR; Schrag A; Nath U; Burn D; Quinn NP; Daniel S; Wood NW; Lees AJ
    Neurosci Lett; 2001 Oct; 312(2):118-20. PubMed ID: 11595348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical findings: Atypical parkinsonian syndromes or Atypical parkinsonian syndromes look-alikes.
    Calikusu FZ; Akkus S; Kochan Kizilkilic E; Poyraz BC; Altunç AT; Kiziltan G; Gunduz A
    Clin Neurol Neurosurg; 2023 Oct; 233():107975. PubMed ID: 37734268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
    Gan J; Chen Z; Liu S; Shi Z; Liu Y; Wang XD; Liu C; Ji Y
    BMC Neurol; 2022 Sep; 22(1):355. PubMed ID: 36123648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE.
    Morris HR; Vaughan JR; Datta SR; Bandopadhyay R; Rohan De Silva HA; Schrag A; Cairns NJ; Burn D; Nath U; Lantos PL; Daniel S; Lees AJ; Quinn NP; Wood NW
    Neurology; 2000 Dec; 55(12):1918-20. PubMed ID: 11134398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
    Tsuboi Y; Josephs KA; Cookson N; Dickson DW
    Neurology; 2003 Jan; 60(2):240-5. PubMed ID: 12552038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility variants in parkinsonism.
    Soto-Ortolaza AI; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.
    Schottlaender LV; Polke JM; Ling H; MacDoanld ND; Tucci A; Nanji T; Pittman A; de Silva R; Holton JL; Revesz T; Sweeney MG; Singleton AB; Lees AJ; Bhatia KP; Houlden H
    Neurobiol Aging; 2015 Feb; 36(2):1221.e1-6. PubMed ID: 25308964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Kaiserova M; Chudackova M; Prikrylova Vranova H; Mensikova K; Kastelikova A; Stejskal D; Kanovsky P
    Neurodegener Dis; 2021; 21(1-2):30-35. PubMed ID: 34695830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder.
    Gan-Or Z; Montplaisir JY; Ross JP; Poirier J; Warby SC; Arnulf I; Strong S; Dauvilliers Y; Leblond CS; Hu MTM; Högl B; Stefani A; Monaca CC; De Cock VC; Boivin M; Ferini-Strambi L; Plazzi G; Antelmi E; Young P; Heidbreder A; Barber TR; Evetts SG; Rolinski M; Dion PA; Desautels A; Gagnon JF; Dupré N; Postuma RB; Rouleau GA
    Neurobiol Aging; 2017 Jan; 49():218.e13-218.e15. PubMed ID: 27814994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.